Patients often present to our practice with oral characteristics of their underlying diagnosis which are difficult to treat including clenching/bruxism, resistance to brushing and drooling.

While an established role has been carved for the role of botulinum toxin among the general population, its use in the management of the aforementioned indications among our patients with special healthcare needs is less frequently offered as a treatment modality.

The ISDH hosted this webinar on Wednesday 08 December as we discussed the role of patients with botulinum toxin in patients with special healthcare needs presented by Dr. Caitriona Kieran.

Caitriona is currently working in a private aesthetics practice and is also a clinical supervisor, teaching advanced restorative to undergraduate students in the Dublin Dental Hospital, TCD. She spent four years working in the NHS before returning to Dublin, where up until recently she was working in private dental practice.

She is in the final year of her masters in Aesthetic Medicine with Queen Mary University of London. Her thesis is entitled, “Can Botulinum Toxin A be used as a primary treatment in the management of bruxism?”

She qualified with honours from Trinity College Dublin in 2010. After graduation she completed a postgraduate vocational training year in Glasgow, Scotland and is a member of the Royal College of Surgeons of Edinburgh.

She has spent time working with various dental charities such as Dentaid in Vietnam and most recently in the refugee camps in Northern Greece.

After many years of using traditional splint therapy for bruxism she has found Botulium toxin to be a particularly useful addition or replacement to traditional therapy.

Learning Objectives:

• To understand Botulium toxin and its mechanism of action
• To identify patients who are suitable for treatment with Botulium toxin
• To outline the treatment protocol and how to deal with potential complications